Sheng-Mai-San is protective against post-ischemic myocardial dysfunction in rats through its opening of the mitochondrial KATP channels

Circ J. 2002 Aug;66(8):763-8. doi: 10.1253/circj.66.763.

Abstract

The present study used isolated rat hearts to investigate whether (1) Sheng-Mei-San (SMS), a traditional Chinese formulation comprising Radix Ginseng, Radix Ophiopogonis and Fructus Schisandrae, is protective against post-ischemic myocardial dysfunction, and (2) whether the cardioprotective effect of SMS is related to scavenging of hydroxyl radicals and opening the mitochondrial KATP channels. The excised hearts of male Sprague-Dawley rats were perfused on a Langendorff apparatus with Krebs-Henseleit solution with a gas mixture of 95% O2 and 5% CO2. Left ventricular end-diastolic pressure (LVEDP, mmHg), left ventricular developed pressure (LVDP, mmHg), +/-dP/dt (mmHg/s) and coronary flow (ml/min) were continuously monitored. All hearts were perfused for a total of 120 min consisting of a 30-min pre-ischemic period followed by a 30-min global ischemia and 60-min reperfusion. Lactate, lactate dehydrogenase (LDH) and 2,5-dihydroxybenzoic acid (2,5-DHBA) concentrations in the effluent were measured during reperfusion. Three days' treatment with SMS (1.67 ml/kg per day) inhibited the rise in LVEDP and improved the post-ischemic LVDP and +/-dP/dt significantly better than in the untreated control hearts during reperfusion. SMS increased the coronary flow at baseline, and during reperfusion. Pretreatment with 5-hydroxydecanoic acid (5-HD), a mitochondrial KATP channel blocker, abolished the inhibition of the rise in LVEDP, the increase in coronary flow and the improvement in LVDP and +/-dP/dt induced by SMS. SMS significantly attenuated the concentrations of lactate, LDH and 2,5-DHBA during reperfusion, but the pretreatment with 5-HD restored them; 5-HD alone did not affect the concentrations. SMS improved the post-ischemic myocardial dysfunction through opening the mitochondrial KATP channels.

MeSH terms

  • Adenosine Triphosphate / metabolism*
  • Animals
  • Cardiomyopathies / prevention & control*
  • Cardiotonic Agents / therapeutic use*
  • Drug Combinations
  • Drugs, Chinese Herbal / therapeutic use*
  • Gentisates*
  • Hydroxybenzoates / metabolism
  • In Vitro Techniques
  • L-Lactate Dehydrogenase / metabolism
  • Lactic Acid / metabolism
  • Male
  • Mitochondria, Heart / metabolism*
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / physiopathology
  • Myocardium / metabolism
  • Potassium Channels / drug effects
  • Potassium Channels / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function
  • Ventricular Function, Left

Substances

  • Cardiotonic Agents
  • Drug Combinations
  • Drugs, Chinese Herbal
  • Gentisates
  • Hydroxybenzoates
  • Potassium Channels
  • fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
  • Lactic Acid
  • Adenosine Triphosphate
  • L-Lactate Dehydrogenase
  • 2,5-dihydroxybenzoic acid